NCT03551288View on ClinicalTrials.gov

Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

July 10, 2018

Study Completion Date

July 16, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

SUVN-911

Tablet

Trial Locations (1)

66211

IQVIA Phase One Services, LLC, Kansas City

All Listed Sponsors
lead

Suven Life Sciences Limited

INDUSTRY

NCT03551288 - Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects | Biotech Hunter | Biotech Hunter